869663-56-9

Basic information

• Product Name: 4-(5-AMINO-3-TERT-BUTYL-PYRAZOL-1-YL)-BENZOIC ACID
• Synonyms: 4-(5-AMINO-3-TERT-BUTYL-1H-PYRAZOL-1-YL)BENZOIC ACID;4-(5-AMINO-3-TERT-BUTYL-PYRAZOL-1-YL)-BENZOIC ACID;TIMTEC-BB SBB012049
• CAS NO: 869663-56-9
• Molecular Formula: C₁₄H₁₇N₃O₂
• Molecular Weight: 259.3
• Mol File: 869663-56-9.mol
• Article Data: 7

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-(5-AMINO-3-TERT-BUTYL-PYRAZOL-1-YL)-BENZOIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(5-AMINO-3-TERT-BUTYL-PYRAZOL-1-YL)-BENZOIC ACID(869663-56-9)
• EPA Substance Registry System: 4-(5-AMINO-3-TERT-BUTYL-PYRAZOL-1-YL)-BENZOIC ACID(869663-56-9)

Safety Data

• Hazard Codes: Xi
• HazardClass: IRRITANT
• Hazardous Substances Data: 869663-56-9(Hazardous Substances Data)

Upstream product

• 59997-51-2 trimethylacetylacetonitrile 
• 24589-77-3 4-hydrazinobenzoic acid hydrochloride 
• 619-67-0 4-Hydrazinobenzoic acid 

Downstream Products

• 876300-04-8 3-tert-butyl-1-(4-((tert-butyldimethylsilyloxy)methyl)phenyl)-1H-pyrazol-5-amine 
• 1229649-45-9 N-(4-((4-(3-(3-tert-butyl-1-(4-(hydroxymethyl)phenyl)-1H-pyrazol-5-yl)ureido)naphthalen-1-yloxy)methyl)pyridin-2-yl)-2-methoxyacetamide 
• 1337932-30-5 1-(4-(4-(3-(3-(tert-butyl)-1-(4-(((tert-butyldimethylsilyl)oxy)methyl)phenyl)-1H-pyrazol-5-yl)ureido)-2,3-dichlorophenoxy)pyrimidin-2-yl)-3-methylurea 
• 1337930-88-7 1-(4-(4-(3-(3-tert-butyl-1-(4-(hydroxymethyl)phenyl)-1H-pyrazol-5-yl)ureido)-2,3-dichlorophenoxy)pyrimidin-2-yl)-3-methylurea 
• 1337932-29-2 N-(6-(4-(3-(3-(tert-butyl)-1-(4-(tert-butyldimethylsilyloxymethyl)phenyl)-1H-pyrazol-5-yl)ureido)-2,3-dichlorophenoxy)pyrimidin-4-yl)-4-(dimethylamino)butanamide 
• 1337930-85-4 N-(6-(4-(3-(3-tert-butyl-1-(4-(hydroxymethyl)phenyl)-1H-pyrazol-5-yl)ureido)-2,3-dichlorophenoxy)pyrimidin-4-yl)-4-(dimethylamino)butanamide 
• 1337932-27-0 tert-butyl 2-(4-(4-(3-(3-tert-butyl-1-(4-((tert-butyldimethylsilyloxy)methyl)phenyl)-1H-pyrazol-5-yl)ureido)-2,3-dichlorophenoxy)pyridin-2-ylamino)-2-oxoethyl(methyl)carbamate 
• 1337930-71-8 N-(4-(4-(3-(3-tert-butyl-1-(4-(hydroxymethyl)phenyl)-1H-pyrazol-5-yl)ureido)-2,3-dichlorophenoxy)pyridin-2-yl)-2-(methylamino)acetamide 
• 725686-68-0 methyl 4-(5-amino-3-tert-butyl-1H-pyrazol-1-yl)benzoate 
• 1337932-37-2 C₃₄H₃₉Cl₂N₇O₆ 

Relevant articles and documents

POLYAROMATIC UREA DERIVATIVES AND THEIR USE IN THE TREATMENT OF MUSCLE DISEASES

The current invention provides urea derivatives, in particular compounds having the core structure heteroaryl-NH-CO-NH-aryl-O- heteroaryl, for use in treating, ameliorating, delaying, curing and/ or preventing a disease or condition associated with muscle cells and/or satellite cells, such as Duchenne muscular dystrophy, Becker muscular dystrophy, cachexia or sarcopenia.

DISUBSTITUTED UREAS AS KINASE INHIBITORS

The invention relates to compounds of the formula (I), their use as kinase inhibitors, new pharmaceutical formulations comprising said compounds, said compounds for use in the diagnostic or therapeutic treatment of warm-blooded animals, especially humans,

Three substituted 4-pyrazolylbenzoates: Hydrogen-bonded supramolecular structures in one, two and three dimensions

The molecules of ethyl 4-(5-amino-3-methyl-1H-pyrazol-1-yl)benzoate, C 13H15N3O2, are linked by two independent N - H...-O hydrogen bonds into a chain of edge-fused and alternating R42(8) a